Presentation is loading. Please wait.

Presentation is loading. Please wait.

The McGill Interdisciplinary Initiative in Infection and Immunity: MI4

Published byMilo Jacobs Modified over 6 years ago

Similar presentations

Presentation on theme: "The McGill Interdisciplinary Initiative in Infection and Immunity: MI4"— Presentation transcript:

1 The McGill Interdisciplinary Initiative in Infection and Immunity: MI4
Donald Sheppard

2 The challenge McGill infection and immunity research
World class researchers and small-moderate teams Geographically and administratively dispersed Resources fragmented, not centrally planned No McGill wide brand or identity History of competition between units rather than collaboration Funding climate is changing Low success rates from traditional sources (i.e. CIHR) Team research critical to success Requires organized, comprehensive teams with established track record of success

3 A McGill-led Solution….
MI4: McGill Interdisciplinary Initiative in Infection and Immunity A McGill-wide institute that brings together and supports the infection and immunity community to accelerate the pace and impact of research and training. ….to a Global Challenge

4 Our Vision Our Approach
To leverage the power of translational research for the prevention, cure and elimination of major infectious and immune threats to health in the 21st century. Our Approach To move past antibiotics and non-selective immunotherapies and develop innovative multidisciplinary solutions for infectious and immune diseases

5 Strategic priority areas
Antimicrobial resistance Emerging / re-emerging diseases Infectious and immune diseases in vulnerable populations Diseases of altered immunity

6 Stakeholders MUHC and MUHC RI McDonald Campus MI4 Family Medicine SMH and Lady Davis Institute JGH and McGill Downtown Campus Community of > 200 researchers and clinicians from across all McGill institutions

7 Expertise across the pillars
Fundamental Science Epidemiology & Population Health Clinical Research MI4 Health Services, Implementation and Policy

8 Key Contributors Fundamental Science Health Science Departments
Faculty of Science Departments Faculty of Agriculture Departments Institute of Parasitology Infectious Diseases in Global Health Centre of Excellence in Translational Immunology Goodman and Segal Cancer Centres Stem Cell and Regenerative Medicine Program Computational Medicine (C3G) McGill Centres: Complex Traits AIDS Centre/Emerging and Complex Viral Infections Microbiome and Disease Tolerance International Tuberculosis Fundamental Science

9 Epidemiology & Population Health
Key Contributors School of Population and Global Health Institute of Parasitology Centre for Outcomes Research Department of Epidemiology Department of Biology Centre for Clinical Epidemiology (LDI) Biostatistics Public Health Chronic Viral Illness Service Center of Excellence in Systemic Autoimmune diseases and Rheumatology Respiratory Epidemiology and Clinical Research Unit Epidemiology & Population Health

10 Health Services Implementation and Policy
Key Contributors Institute for Health and Social Policy School of Population and Global Health Institute of Parasitology McGill International TB Centre Faculty of Law Centre for Outcomes Research Department of Epidemiology Department of Public Health Chronic Viral Illness Service MUHC Clinical Practice Assessment Unit J.D. MacLean Centre for Tropical Diseases Health Services Implementation and Policy

11 Key Contributors Clinical Research
McGill International Tuberculosis Centre McGill AIDS Centre Chronic Viral Illness Service MISTIC* Center of Excellence in Systemic Autoimmune diseases and Rheumatology McGill Rossy Cancer Network Centre for Innovative Medicine MUHC Vaccine Study Centre McGill IBD Centre of Excellence Respiratory Epidemiology and Clinical Research Unit Infectious Disease Susceptibility Program Global Health Programs McGill C. difficile Study Group Clinical Research

12 What will MI4 accomplish?
Comprehensive solutions to complex problems: Moving beyond antibiotics: vaccines, antibodies, proteins, microorganisms and cells that reprogram immune responses to enhance protective activity against pathogens Hacking the immune system: a platform to develop and implement novel immunotherapies for cancer and inflammatory diseases Disease detection: point-of-care (POC) and innovative diagnostics for infectious and immune diseases Eradicating infectious diseases: elimination of TB and Hepatitis C virus transmission in vulnerable Canadian communities as a model for the world Local importance and global impact where we can show the world the way

13 Foster interdisciplinary and inter-institutional research:
What will MI4 accomplish? Foster interdisciplinary and inter-institutional research: Training programs: partner with existing departments and programs to develop co-training models to serve as nodes Seed grants: small one-time funding opportunities to bring together new teams to tackle priority areas Shared platforms: personnel support, resource sharing and strategic planning to maximize platform usefulness and lifespan Secure large scale funding: early identification, project management and identification of co-funding for large scale initiatives (SPORE, NCE, JPIAMR, CERC) Local importance and global impact where we can show the world the way

14 Engage and inspire our students:
What will MI4 accomplish? Engage and inspire our students: Attract: Develop exciting, groundbreaking initiatives that will be a magnet for the best and brightest Interact: Embrace a philosophy that fosters innovation through cross- discipline training Act: Help students realize their ambitions to become a global force for change

15 Progress to date: Inaugural MI4 Strategic Forum
Brainstorming meeting of 125 researchers: Priority areas Interdisciplinary projects Training initiatives >40 proposals for research programs submitted Presentation to University Advancement Shared our vision with UA team and advisors Well-received and greenlighted to move forward as a McGill Grand Challenge Next task is preparation of Faculty case for support

16 Ongoing work Strategic plan development Establish our position
Workgroup established, meeting this week Develop a governance plan Define science, priority programs and vision Determine our needs and draft a budget Identify the role for donor support in a comprehensive funding plan Establish our position Build our research teams and programs Generate performance metrics and comparator data Develop provincial, national and international partnerships

17 Roadmap to funding Identify and prepare for team grant and large scale funding opportunities Ongoing Large foundation LOI submitted JPIAMR initiative shortlisted for funding CIFAR in preparation Partner in two NCE applications Future opportunities CERC and CFREF MESI-FACS FRQS – Reseau European Research Agency partnerships JPIAMR network

18 MI4 Development Timeline
Strategic plan and institute proposal submitted Faculty case for support completed 1st External funding application submitted Research teams established Feb 21 - Apr 10 Institute approved internally Feb 28 - Apr 22 Mar 10 - Apr 21 Training programs established Apr 2 - May 31 2018 2019 2020 May 5 - Jun 18

19 Questions?

20 MI4 Governance

Download ppt "The McGill Interdisciplinary Initiative in Infection and Immunity: MI4"

Similar presentations

Building a Strategic Management System Office for Student Affairs, Twin Cities Campus Ground Level Work Metrics Initiatives Managing Change Change Management.

Building a Strategic Management System Office for Student Affairs, Twin Cities Campus Ground Level Work Metrics Initiatives Managing Change Change Management.
SCHOOL OF HEALTH RELATED PROFESSIONS STRATEGIC PLAN 2003 DRAFT.

SCHOOL OF HEALTH RELATED PROFESSIONS STRATEGIC PLAN 2003 DRAFT.
University of Houston Health Science Center Initiative.

University of Houston Health Science Center Initiative.
1 The Duke Global Health Institute’s Health Systems Strengthening Areas of Expertise Caroline Hope Griffith Associate in Research Aisha Jafri Associate.

1 The Duke Global Health Institute’s Health Systems Strengthening Areas of Expertise Caroline Hope Griffith Associate in Research Aisha Jafri Associate.
Social Sciences and Humanities Research Council of Canada Conseil de recherches en sciences humaines du Canada April 27, 2010 Presentation to the 2010.

Social Sciences and Humanities Research Council of Canada Conseil de recherches en sciences humaines du Canada April 27, 2010 Presentation to the 2010.
Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.

Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.
The NIH Roadmap for Medical Research www.nihroadmap.nih.gov www.nihroadmap.nih.gov.

The NIH Roadmap for Medical Research
Public Health and Healthcare in Ontario A Made in Ontario Solution for Public Health and Healthcare Andrew Papadopoulos Director, School of Occupational.

Public Health and Healthcare in Ontario A Made in Ontario Solution for Public Health and Healthcare Andrew Papadopoulos Director, School of Occupational.
Emerging infections and Health Protection In Scotland Looking to the future Kirsty Roy and Martin Donaghy Health Protection Scotland Scottish Government.

Emerging infections and Health Protection In Scotland Looking to the future Kirsty Roy and Martin Donaghy Health Protection Scotland Scottish Government.
Recognition Of Team Science Faculty Appointments, Promotions and Titles at The Geisel School of Medicine at Dartmouth “Recognition by peers as an investigator.

Recognition Of Team Science Faculty Appointments, Promotions and Titles at The Geisel School of Medicine at Dartmouth “Recognition by peers as an investigator.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,

Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
1 The Federal Shared Youth Vision Partnership A Federal Partnership between the Corporation for National community Service;

1 The Federal Shared Youth Vision Partnership A Federal Partnership between the Corporation for National community Service;
The Need for Training on Team and Meeting Management to Enhance Capacity for Team Science Kady Nearing, Senior Evaluator The Evaluation Center Colorado.

The Need for Training on Team and Meeting Management to Enhance Capacity for Team Science Kady Nearing, Senior Evaluator The Evaluation Center Colorado.
1 Investing in America’s Future The National Science Foundation Strategic Plan for FY 2006-2011 Advisory Committee for Cyberinfrastructure 10/31/06 Craig.

1 Investing in America’s Future The National Science Foundation Strategic Plan for FY Advisory Committee for Cyberinfrastructure 10/31/06 Craig.
6 Key Priorities A “scorecard” for each of the 5 above priorities with end of 2009 deliverables – with a space beside each for a check mark (i.e. complete)

6 Key Priorities A “scorecard” for each of the 5 above priorities with end of 2009 deliverables – with a space beside each for a check mark (i.e. complete)
1 The Federal Shared Youth Vision Partnership A Federal Partnership between the United States Departments of Education, Health.

1 The Federal Shared Youth Vision Partnership A Federal Partnership between the United States Departments of Education, Health.
Integration of HIV/AIDS, STD, TB and Viral Hepatitis New York State’s Experience Guthrie S. Birkhead, M.D., M.P.H. Director, AIDS Institute Director, Center.

Integration of HIV/AIDS, STD, TB and Viral Hepatitis New York State’s Experience Guthrie S. Birkhead, M.D., M.P.H. Director, AIDS Institute Director, Center.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.

The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.

University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.

Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.

Similar presentations

Ads by Google